Tigress Financial Maintains Buy on Legence, Raises Price Target to $130
Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $125 to $130.
Read original at benzingaStocks · News reference
These Analysts Revise Their Forecasts On Legence Following Q2 Results
Legence Corp (NASDAQ: LGN) reported mixed Q2 results, missing earnings estimates but beating sales expectations. Analysts lowered price targets.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 14, 2026, 12:46 PM
- Checked
- Aug 14, 2026, 12:46 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Legence Corp. (LGN)
Filed: 2026-08-18 AccNo: 0001193125-26-355583 Size: 141 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Read original at edgarGuggenheim Reiterates Buy on Legence, Maintains $115 Price Target
Guggenheim analyst Joseph Osha reiterates Legence (NASDAQ:LGN) with a Buy and maintains $115 price target.
Read original at benzingaB of A Securities Maintains Buy on Legence, Raises Price Target to $116
B of A Securities analyst Sherif El-Sabbahy maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $105 to $116.
Read original at benzinga